Skip to main content

Peer Review reports

From: Cryptolepine inhibits hepatocellular carcinoma growth through inhibiting interleukin-6/STAT3 signalling

Original Submission
14 Mar 2021 Submitted Original manuscript
27 Mar 2021 Reviewed Reviewer Report
1 Apr 2021 Reviewed Reviewer Report
19 Apr 2021 Author responded Author comments - Mohamed Mutocheluh
20 Apr 2021 Author responded Author comments - Mohamed Mutocheluh
Resubmission - Version 2
19 Apr 2021 Submitted Manuscript version 2
20 Apr 2021 Author responded Author comments - Mohamed Mutocheluh
Resubmission - Version 3
20 Apr 2021 Submitted Manuscript version 3
24 Apr 2021 Reviewed Reviewer Report
26 Apr 2021 Reviewed Reviewer Report
3 May 2021 Author responded Author comments - Mohamed Mutocheluh
Resubmission - Version 4
3 May 2021 Submitted Manuscript version 4
7 May 2021 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
11 May 2021 Editorially accepted
2 Jun 2021 Article published 10.1186/s12906-021-03326-x

You can find further information about peer review here.

Back to article page